The Connexus system. [Image courtesy of Paradromix]

Connexus系统。[图片由Paradromix提供]

Paradromics announced today that it received a strategic investment from NEOM, a region taking shape in Saudi Arabia.

Paradromics今天宣布，它接受了沙特阿拉伯正在形成的NEOM地区的战略投资。

Crown Prince Mohammad bin Salman launched the NEOM region project in 2017. Plans include a floating industrial complex, global trade hub, tourist resorts and a linear city powered by renewable energy sources.

2017年，穆罕默德·本·萨尔曼王储启动了NEOM地区项目。计划包括一个漂浮的工业综合体、全球贸易中心、旅游胜地和一个由可再生能源供电的线性城市。

The NEOM Investment Fund (NIF) leads the partnership to advance the development of brain-computer interface (BCI) therapies. BCI therapies seek to restore, enhance or replace lost neurological functions for those with conditions that impair movement, communication or cognitive function.

NEOM投资基金（NIF）领导该伙伴关系，以推动脑-计算机接口（BCI）疗法的发展。。

“This partnership marks a pivotal moment for Paradromics and the broader BCI industry,” said Matt Angle, Paradromics founder and CEO. “NEOM and Paradromics both have expansive visions for the future of mental health that are highly aligned. Working together, we can accelerate the rate of innovation in BCI and expand access to impactful BCI-based therapies.”.

Paradromics创始人兼首席执行官马特·安格尔（MattAngle）表示：“这一合作关系标志着Paradromics和更广泛的BCI行业的关键时刻。“NEOM和Paradromics都对心理健康的未来有着高度一致的广阔愿景。通过合作，我们可以加快脑机接口的创新速度，并扩大对基于脑机接口的有效疗法的获取。”。

As part of the agreement, NEOM and Paradromics intend to establish a BCI Center of Excellence within the region. They seek to spearhead ambitious clinical research and eventually serve as the premier center for BCI-based healthcare in the MENA region and beyond.

作为协议的一部分，NEOM和Paradromics打算在该地区建立一个BCI卓越中心。他们寻求引领雄心勃勃的临床研究，并最终成为中东和北非地区及其他地区基于BCI的医疗保健的首要中心。

Paradromics (Austin, Texas) develops the FDA breakthrough Connexus BCI system. It has the potential to help patients communicate after losing the ability to speak and control computer devices.

Paradromics（德克萨斯州奥斯汀）开发了FDA突破性的Connexus BCI系统。它有可能帮助患者在失去说话和控制计算机设备的能力后进行沟通。

“At NIF, we are committed to enabling NEOM’s bold vision of redefining the future of healthcare by investing in transformative technologies that push boundaries and address humanity’s toughest challenges,” said Majid Mufti, CEO of NIF. “Paradromics was selected as a strategic partner for their groundbreaking advancements in BCIs and our shared mission of shaping industries, solving critical challenges and driving meaningful impact.”.

NIF首席执行官马吉德·穆夫蒂（MajidMufti）表示：“在NIF，我们致力于通过投资变革性技术，推动突破界限，解决人类最严峻的挑战，实现NEOM重新定义医疗保健未来的大胆愿景。”。“Paradromics被选为战略合作伙伴，因为他们在BCIs方面取得了突破性进展，我们的共同使命是塑造行业，解决关键挑战并推动有意义的影响。”。

More about Paradromics and BCIs

关于Paradromics和BCI的更多信息

The Paradromics BCI system translates recorded brain signals into actionable health data. Initially, the company’s focus centers around restoring

Paradromics BCI系统将记录的大脑信号转换为可行的健康数据。最初，公司的重点是恢复

independent communication through digital devices for individuals living with spinal cord injuries, stroke, or ALS, a motor neuron disease.

通过数字设备为患有脊髓损伤、中风或ALS（一种运动神经元疾病）的个体进行独立通信。

Paradromics also plans to develop future applications for mental health conditions, such as mood disorders and chronic pain. The fully implantable BCI can record from single neurons, using durable materials and packaging. Advantages could include the ability to obtain high-resolution data over long periods of time.

Paradromics还计划开发未来用于心理健康状况的应用，如情绪障碍和慢性疼痛。完全植入式BCI可以使用耐用的材料和包装从单个神经元记录。优点可能包括能够长时间获得高分辨率数据。

This data can enable complex applications like decoding intended speech..

这些数据可以实现复杂的应用，例如解码预期语音。。

The company

公司

was accepted into the FDA Total Product Life Cycle Advisory (TAP) program in July 2024

于2024年7月被FDA总产品生命周期咨询（TAP）计划接受

. In preparation for a clinical trial in 2025, the company also launched a patient registry so patients can submit interest. The company featured on

为了准备2025年的临床试验，该公司还推出了患者登记册，以便患者可以提交兴趣。该公司在

MassDevice’s

MassDevice的

2024 lists of

2024年

BCI companies to know

BCI公司需要了解

and

和

neurotech companies to know

需要了解的神经科技公司

.

.

Paradromics’ latest investment marks another sign of the ever-growing BCI space. Companies like Neuralink, Synchron and Blackrock Neurotech have long been seen as the leaders, but a number of companies aim to be the first to bring a BCI to market.

Paradromics的最新投资标志着BCI空间不断扩大的另一个迹象。。

Analysts said last year that they see a massive market opportunity for the technology

分析人士去年表示，他们看到了这项技术的巨大市场机会

.

.